Saturday 27 November 2021

Merck Says Its Covid Pill Is Less Effective in a Final Analysis

The drug, molnupiravir, reduced the risk of hospitalization and death in high-risk Covid patients by 30 percent. An earlier analysis had found a 50 percent reduction.

from NYT > Top Stories https://ift.tt/3p2BTlU
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Who Will Be U.K. Conservative Leader? The Contest Narrows to an Unexpected Choice.

After an epic election defeat in July, opposition lawmakers have presented their party’s dues-paying members with an unexpected choice of tw...